Lv51
980 积分 2025-06-17 加入
VRON-0200 alone and in combination with investigational antivirals for participants with chronic hepatitis B virus infection receiving stable nucleos(t)ide therapy: a phase 1b, randomised, open-label, multicentre trial
10天前
已完结
Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis
10天前
已完结
Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma
18天前
已完结
Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold
28天前
已完结
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity
1个月前
已完结
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D
1个月前
已完结
Hepatitis D
1个月前
已完结
Intrahepatic and peripheral immunophenotyping of participants with chronic hepatitis B receiving bepirovirsen in the B-Fine study strongly suggests that bepirovirsen may trigger a humoral response
1个月前
已关闭
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
1个月前
已完结
Chronic Hepatitis B: Current Understanding and Clinical Implications of Immune Exhaustion
2个月前
已完结
小儿扁桃体切除术围术期镇痛研究进展
11个月前
已采纳
皖公网安备34019202002308
